Innealta Capital’s PetMed Express PETS Stock Holding History

Innealta Capital’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-17	Closed	-$69	–	1245
2024 Q2	$69	Buy	+17	New	+$73	﹤0.01%	1723

Other funds holding PETS

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Metavasi Capital Larchmont, New York $276M AUM 92.83% 1-Year Est. Return

Innealta Capital's PETS Position: Q3 2024 in Review

Innealta Capital sold out of PetMed Express (PETS) in Q3 2024, closing a stake of 17 shares — an estimated $69 sold.

Innealta Capital first reported a position in PETS in Q2 2024 and held it in 1 quarter. The position peaked at $69 in Q2 2024. 93 funds tracked by Wall St. Rank hold PETS as of Q3 2024.

Innealta Capital reported no remaining PetMed Express position as of Q3 2024 after selling out during the quarter.
Innealta Capital sold 17 PetMed Express shares in Q3 2024, an estimated $69.
Innealta Capital first reported a position in PetMed Express in Q2 2024 and held it in 1 quarter.
Innealta Capital's PetMed Express position peaked at $69 in Q2 2024.
93 funds tracked by Wall St. Rank held PetMed Express as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.